skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 184  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Material Type:
Article
Add to My Research

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

The Lancet (British edition), 2014-03, Vol.383 (9921), p.955-962 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 15, 2014 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)62343-0 ;PMID: 24315724 ;CODEN: LANCAO

Full text available

2
Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
Material Type:
Article
Add to My Research

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

Circulation (New York, N.Y.), 2019-05, Vol.139 (22), p.2528-2536 [Peer Reviewed Journal]

2019 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.119.040130 ;PMID: 30882238

Full text available

3
Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
Material Type:
Article
Add to My Research

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial

The Lancet (British edition), 2015-06, Vol.385 (9984), p.2288-2295 [Peer Reviewed Journal]

Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 6, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61943-7 ;PMID: 25769361 ;CODEN: LANCAO

Full text available

4
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial
Material Type:
Article
Add to My Research

Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial

Journal of the American College of Cardiology, 2017-03, Vol.69 (11), p.1372-1382 [Peer Reviewed Journal]

The Authors ;2017 The Authors ;Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Mar 21, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2016.12.031 ;PMID: 28302288

Full text available

5
Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial
Material Type:
Article
Add to My Research

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial

Journal of the American Heart Association, 2016-05, Vol.5 (5), p.n/a [Peer Reviewed Journal]

2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.116.003432 ;PMID: 27207971

Full text available

6
The importance of dosing frequency on the safety of DOACs
Material Type:
Article
Add to My Research

The importance of dosing frequency on the safety of DOACs

American heart journal plus, 2022-11, Vol.23, p.100216-100216, Article 100216 [Peer Reviewed Journal]

2022 The Author ;2022 The Author. ;ISSN: 2666-6022 ;EISSN: 2666-6022 ;DOI: 10.1016/j.ahjo.2022.100216 ;PMID: 38560657

Full text available

7
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48
Material Type:
Article
Add to My Research

Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48

European heart journal, 2014-06, Vol.35 (22), p.1457-1465 [Peer Reviewed Journal]

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2013. For permissions please email: journals.permissions@oup.com. ;Distributed under a Creative Commons Attribution 4.0 International License ;Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2013. For permissions please email: journals.permissions@oup.com. 2013 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/eht500 ;PMID: 24302269

Full text available

8
The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
Material Type:
Article
Add to My Research

The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism

Circulation (New York, N.Y.), 2020-05, Vol.141 (20), p.1600-1607 [Peer Reviewed Journal]

2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.120.046397 ;PMID: 32223429

Full text available

9
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)
Material Type:
Article
Add to My Research

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)

The American heart journal, 2010-10, Vol.160 (4), p.635-641.e2 [Peer Reviewed Journal]

Mosby, Inc. ;2010 Mosby, Inc. ;2015 INIST-CNRS ;Copyright © 2010 Mosby, Inc. All rights reserved. ;Copyright Elsevier Limited Oct 2010 ;ISSN: 0002-8703 ;EISSN: 1097-6744 ;DOI: 10.1016/j.ahj.2010.06.042 ;PMID: 20934556 ;CODEN: AHJOA2

Full text available

10
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial
Material Type:
Article
Add to My Research

Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial

The Lancet (British edition), 2015-06, Vol.385 (9984), p.2280-2287 [Peer Reviewed Journal]

Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 6, 2015 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61994-2 ;PMID: 25769357 ;CODEN: LANCAO

Full text available

11
Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillation
Material Type:
Article
Add to My Research

Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillation

PloS one, 2021-03, Vol.16 (3), p.e0248134-e0248134 [Peer Reviewed Journal]

COPYRIGHT 2021 Public Library of Science ;COPYRIGHT 2021 Public Library of Science ;2021 Ravvaz et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Ravvaz et al 2021 Ravvaz et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0248134 ;PMID: 33735259

Full text available

12
Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation – An ENGAGE AF-TIMI 48 Subanalysis
Material Type:
Article
Add to My Research

Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation – An ENGAGE AF-TIMI 48 Subanalysis

Circulation Journal, 2016/03/25, Vol.80(4), pp.860-869 [Peer Reviewed Journal]

2016 THE JAPANESE CIRCULATION SOCIETY ;ISSN: 1346-9843 ;EISSN: 1347-4820 ;DOI: 10.1253/circj.CJ-15-1082 ;PMID: 26888149

Full text available

13
Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial
Material Type:
Article
Add to My Research

Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF - TIMI 48 Trial

Journal of the American Heart Association, 2018-08, Vol.7 (16), p.e008987 [Peer Reviewed Journal]

2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.118.008987 ;PMID: 30369307

Full text available

14
A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial
Material Type:
Article
Add to My Research

A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial

European heart journal, 2017-03, Vol.38 (12), p.888 [Peer Reviewed Journal]

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2017. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehw565 ;PMID: 28064150

Full text available

15
Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial
Material Type:
Article
Add to My Research

Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial

Journal of the American Heart Association, 2016-02, Vol.5 (2), p.n/a [Peer Reviewed Journal]

2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.115.002587 ;PMID: 26908401

Full text available

16
No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab
Material Type:
Article
Add to My Research

No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab

PloS one, 2022-04, Vol.17 (4), p.e0266615-e0266615 [Peer Reviewed Journal]

COPYRIGHT 2022 Public Library of Science ;2022 Korthauer et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;info:eu-repo/semantics/openAccess ;2022 Korthauer et al 2022 Korthauer et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0266615 ;PMID: 35404972

Full text available

17
Evaluation of Direct Oral Anticoagulant Prescribing in Patients With Moderate to Severe Renal Impairment
Material Type:
Article
Add to My Research

Evaluation of Direct Oral Anticoagulant Prescribing in Patients With Moderate to Severe Renal Impairment

Clinical and applied thrombosis/hemostasis, 2021, Vol.27, p.1076029620987900 [Peer Reviewed Journal]

The Author(s) 2021 ;The Author(s) 2021. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 2021 SAGE Publications Inc. unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses ;ISSN: 1076-0296 ;EISSN: 1938-2723 ;DOI: 10.1177/1076029620987900 ;PMID: 33517715

Full text available

18
The Challenge of Getting it Just Right
Material Type:
Article
Add to My Research

The Challenge of Getting it Just Right

Journal of the American College of Cardiology, 2015-08, Vol.66 (7), p.788-790 [Peer Reviewed Journal]

American College of Cardiology Foundation ;Copyright Elsevier Limited Aug 18, 2015 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2015.06.1082

Full text available

19
Effects of Regional Differences in Asia on Efficacy and Safety of Edoxaban Compared With Warfarin – Insights From the ENGAGE AF-TIMI 48 Trial
Material Type:
Article
Add to My Research

Effects of Regional Differences in Asia on Efficacy and Safety of Edoxaban Compared With Warfarin – Insights From the ENGAGE AF-TIMI 48 Trial

Circulation Journal, 2015/11/25, Vol.79(12), pp.2560-2567 [Peer Reviewed Journal]

2015 THE JAPANESE CIRCULATION SOCIETY ;ISSN: 1346-9843 ;EISSN: 1347-4820 ;DOI: 10.1253/circj.CJ-15-0574 ;PMID: 26460886

Full text available

20
Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF‐TIMI 48 Trial
Material Type:
Article
Add to My Research

Sudden Cardiac Death in Patients With Atrial Fibrillation: Insights From the ENGAGE AF‐TIMI 48 Trial

Journal of the American Heart Association, 2016-07, Vol.5 (7), p.n/a [Peer Reviewed Journal]

2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.116.003735 ;PMID: 27402235

Full text available

Results 1 - 20 of 184  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (168)

Refine My Results

Creation Date 

From To
  1. Before 2006  (7)
  2. 2006 To 2010  (7)
  3. 2011 To 2014  (33)
  4. 2015 To 2019  (75)
  5. After 2019  (63)
  6. More options open sub menu

Resource Type 

  1. Articles  (178)
  2. Patents  (4)
  3. Reviews  (1)
  4. Book Chapters  (1)
  5. More options open sub menu

Language 

  1. English  (182)
  2. Japanese  (12)
  3. Chinese  (3)
  4. Russian  (1)
  5. Norwegian  (1)
  6. Korean  (1)
  7. More options open sub menu

Searching Remote Databases, Please Wait